Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · IEX Real-Time Price · USD
0.347
+0.023 (7.21%)
At close: Jul 2, 2024, 4:00 PM
0.348
+0.002 (0.43%)
After-hours: Jul 2, 2024, 7:57 PM EDT

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019
Market Capitalization
7663,5803,27912,355--
Market Cap Growth
-9.42%9.20%-73.46%---
Enterprise Value
1602,8582,37610,827-364-479
PE Ratio
--4.01-1.56-6.75--
PS Ratio
3.6714.246.8639.37--
PB Ratio
0.783.261.898.21--
P/FCF Ratio
-7.84-10.79-10.77-39.81--
P/OCF Ratio
-8.49-12.12-13.00-48.68--
EV/Sales Ratio
0.7711.374.9734.50-4.75-8.83
EV/EBITDA Ratio
-2.48-3.60-1.16-6.013.364.51
EV/EBIT Ratio
-2.21-3.20-1.12-5.922.984.09
EV/FCF Ratio
-5.94-8.61-7.80-34.891.887.15
Debt / Equity Ratio
0.240.200.240.010.040.03
Debt / EBITDA Ratio
-0.31-0.28-0.20-0.01-0.15-0.16
Debt / FCF Ratio
-0.74-0.67-1.36-0.07-0.09-0.25
Quick Ratio
5.125.878.0812.515.5012.55
Current Ratio
5.346.118.3812.795.8312.77
Asset Turnover
0.110.120.230.230.11-
Interest Coverage
-9181.08-9600.51-19998.58-770.82-51.29-48.28
Return on Equity (ROE)
-70.60%-65.40%-133.90%-192.90%-26.50%-
Return on Assets (ROA)
-45.10%-42.50%-99.50%-134.30%-18.40%-
Return on Capital (ROIC)
-67.66%-65.54%-102.76%-119.69%-28.67%-14.04%
Earnings Yield
-111.43%-24.94%-64.20%-14.81%--
FCF Yield
-41.56%-9.27%-9.29%-2.51%--
Buyback Yield / Dilution
-4.63%-15.75%-23.48%-6.72%-10.95%-
Total Shareholder Return
-4.63%-15.75%-23.48%-6.72%-10.95%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).